Lipigon Pharmaceuticals AB
LPGO | FN
Overview
Corporate Details
- ISIN(s):
- SE0015382072
- LEI:
- 549300XPO40YR12SLY87
- Country:
- Sweden
- Address:
- Tvistevägen 48 C, 907 36 Umeå
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Lipigon Pharmaceuticals AB specializes in therapies for lipid-related diseases. Their research focuses on cardiovascular and metabolic disorders.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-12-16 | Johan Living | Other | Buy | 260,000 | 51,688.00 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Cyclezyme AB | Sweden | CYCLE | |
|
Cyxone AB | Sweden | CYXO | |
|
DBV Technologies | France | DBV | |
|
DEINOVE | France | ALDEI | |
|
Deutsche Biotech Innovativ AG | Germany | DBI | |
|
Devyser Diagnostics | Sweden | DVYSR | |
/other/Diamyd_Medical_AB_publ-logo.png?Expires=1749901426&Signature=UadSig7kyCV6riTBtAkqveM6l-4X53WszGlnJczB6kCj1D~aOt2YPdz7mMx5AuCcRu5vUWjbJNJUXlEynaoeXuoUjHOEElUjYxGhktEUaU0cinZtveO-lZ2yx~SuCIx01Dr3WtzDO-bmYuXFE2~pG-Jo7T-SfLOEv-qj3liHOSxjblqht63BF0wb0-2MnyRC53jWcWNW2NLQRDIYnLMJCv17UaMWctzDH8ZwT3ULjPCanvg7ZZX6gWpZJKA9I3DK5CUKh7vCPTzWkqmPePFIw2VQP7KtzrFye6rX47Fa4tadmMHxhSGHNFbfOpGflCClpQAUMNYyh6VmFGQYX6vePg__&Key-Pair-Id=K6QMJA61RGOXQ){kind=logo}
|
Diamyd Medical AB (publ) | Sweden | DMYD | |
|
Diasorin | Italy | DIA | |
| DNA Group (T.R.) Ltd. | Israel | DNA | ||
|
Double Bond Pharmaceutical International AB | Sweden | DBP B |